Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum
- PMID: 11867191
- DOI: 10.1016/s0168-8278(01)00299-9
Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: low GGT cholestasis is a clinical continuum
Abstract
Benign recurrent intrahepatic cholestasis (BRIC) is an autosomal recessive liver disease, characterised by intermittent attacks of cholestasis, which can start at any age and last for several weeks to months. Characteristically serum GGT activity is low and normal liver structure is preserved. Progressive familial intrahepatic cholestasis (PFIC) is another liver disease, characterised by severe cholestasis, starting almost invariably before 6 months of age. All patients progress to cirrhosis, liver failure and death, unless a liver transplantation is performed. We now identified four patients who presented in childhood with recurrent attacks of cholestasis, while in the course of the disease the cholestasis gradually became permanent. Although liver biopsies performed in the early stages of the disease showed normal liver architecture, late stage biopsies revealed evident fibrosis with porto-portal septa formation. In conclusion, the disease of these patients started with the clinical and histopathological characteristics of BRIC but progressed to PFIC.
Similar articles
-
Endoscopic nasobiliary drainage: an effective treatment option for benign recurrent intrahepatic cholestasis (BRIC).BMJ Case Rep. 2017 May 5;2017:bcr2016218874. doi: 10.1136/bcr-2016-218874. BMJ Case Rep. 2017. PMID: 28476903 Free PMC article.
-
Genetic cholestasis: lessons from the molecular physiology of bile formation.Can J Gastroenterol. 2000 Mar;14(3):233-8. doi: 10.1155/2000/514172. Can J Gastroenterol. 2000. PMID: 10758420 Review.
-
Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review.Acta Gastroenterol Belg. 2012 Dec;75(4):405-10. Acta Gastroenterol Belg. 2012. PMID: 23402083 Review.
-
ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): phenotypic differences between PFIC1 and PFIC2 and natural history.Hepatology. 2010 May;51(5):1645-55. doi: 10.1002/hep.23539. Hepatology. 2010. PMID: 20232290
-
Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile.Gastroenterology. 2003 Oct;125(4):1227-34. doi: 10.1016/s0016-5085(03)01199-5. Gastroenterology. 2003. PMID: 14517804
Cited by
-
New paradigms of USP53 disease: normal GGT cholestasis, BRIC, cholangiopathy, and responsiveness to rifampicin.J Hum Genet. 2021 Feb;66(2):151-159. doi: 10.1038/s10038-020-0811-1. Epub 2020 Aug 6. J Hum Genet. 2021. PMID: 32759993
-
Case Report: A Rare Case of Benign Recurrent Intrahepatic Cholestasis-Type 1 With a Novel Heterozygous Pathogenic Variant of ATP8B1.Front Med (Lausanne). 2022 Apr 29;9:891659. doi: 10.3389/fmed.2022.891659. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572954 Free PMC article.
-
Phospholipase D2 mediates signaling by ATPase class I type 8B membrane 1.J Lipid Res. 2013 Feb;54(2):379-85. doi: 10.1194/jlr.M030304. Epub 2012 Dec 4. J Lipid Res. 2013. PMID: 23213138 Free PMC article.
-
Alkaline Phosphatase Pathophysiology with Emphasis on the Seldom-Discussed Role of Defective Elimination in Unexplained Elevations of Serum ALP - A Case Report and Literature Review.Clin Exp Gastroenterol. 2022 Mar 15;15:41-49. doi: 10.2147/CEG.S345531. eCollection 2022. Clin Exp Gastroenterol. 2022. PMID: 35313457 Free PMC article.
-
The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency.PLoS One. 2016 Apr 6;11(4):e0153114. doi: 10.1371/journal.pone.0153114. eCollection 2016. PLoS One. 2016. PMID: 27050426 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous